Safety of the Combination of Intensive Cholesterol-Lowering Therapy with Oral Anticoagulation Medication in Elderly Patients with Atrial Fibrillation: A Randomized, Double-Blind, Placebo-Controlled Study

By Enajat Morteza  

Drugs & Aging, Vol. 26, Iss. 7, 2009-07 ,pp. : 585-593

Adis International

Access to resources Recommend Favorite

Rationale for and Design of the CREATIVE-AF Trial: Randomized, Double-Blind, Placebo-Controlled, Crossover Study of the Effect of Irbesartan on Oxidative Stress and Adhesion Molecules in Patients with Persistent Atrial Fibrillation

By Goette Andreas  

Clinical Drug Investigation, Vol. 28, Iss. 9, 2008-01 ,pp. : 565-572

Adis International

Access to resources Recommend Favorite

Analgesic Efficacy of Quick-Release versus Standard Lornoxicam for Pain after Third Molar Surgery: A Randomized, Double-Blind, Placebo-Controlled, Single-Dose Trial

By Møller Philip L.   Nørholt Sven E.  

Clinical Drug Investigation, Vol. 28, Iss. 12, 2008-01 ,pp. : 757-766

Adis International

Access to resources Recommend Favorite

Effect of twelve-months therapy with oral ambroxol in preventing exacerbations in patients with COPD. Double-blind, randomized, multicenter, placebo-controlled study (the AMETHIST Trial)

By Malerba M.   Ponticiello A.   Radaeli A.   Bensi G.   Grassi V.  

Pulmonary Pharmacology & Therapeutics, Vol. 17, Iss. 1, 2004-02 ,pp. : 27-34

Elsevier

Access to resources Recommend Favorite

Flutamide in unresectable pancreatic adenocarcinoma: A randomized, double-blind, placebo-controlled trial

By Negi Sanjay   Agarwal Anil   Chaudhary Adarsh  

Investigational New Drugs, Vol. 24, Iss. 3, 2006-05 ,pp. : 189-194

Springer Publishing Company

Access to resources Recommend Favorite